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Summary.-In a previous report we have shown that a few substances, especially
thiouracil, are incorporated as false precursors into melanin during its synthesis.
In the present investigation, we have intensified our studies on the incoporation
ofthiouracil into melanotic melanomas. Firstly, thedistribution and retention ofboth
14C- and 35S-labelled thiouracil in mice with transplanted melanomas were studied.
A high and selective accumulation was found in the melanotic tumours. The con-
centration In the rest of the body was low, with the exception of the thyroid gland.
Secondly, melanoma-bearing mice were given increasing doses of thiouracil, and
cultured melanoma cells were exposed to different concentrations of thiouracil, to
investigate the relation between dose and uptake in melanomas and melanoma cells,
respectively. A relatively linear increase in uptake with dose was found, indicating
that the melanin incorporation of thiouracil is non-saturable up to subtoxic levels.
METASTASES frommalignant melanomas
are known to be difficult to localize and
treat successfully (Comis & Carter, 1974).
However, Hornsey (1978) has found that
melanomas respond relatively well to
radiotherapy if proper doses and time
intervals for the treatment are chosen.
This makes techniques for a selective
irradiation of melanomas attractive.
In our group, we have for some time
been interested in finding new methods
for diagnosing and treating melanomas by
using radioactively labelled substances
which are selectively incorporated into
growing melanin as false melanin pre-
cursors. In a preliminary report, we
earlier showed that thiouracil strongly
accumulates in growing melanin, for
example in the eyes ofyoung animals and
in melanotic melanomas. Thiouracil is
apparently used as a false precursor in the
synthesis ofmelanin (Dencker et al., 1979;
1981). The mechanism for this uptake is
thus different from that of many poly-
cyclic amines (e.g. chloroquine, chlor-
promazine), which bind to preformed
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melanin (Potts, 1964; Lindquist & Ullberg,
1972). Binding of this type cannot be
observed for thiouracil.
By labelling thiouracil, or possibly
other sulphur-containing cyclic structures,
with suitable gamma- or positron-emitting
radioisotopes, a localization of even small
metastases or hidden primary melanomas
may be possible. With proper fl-emitting
isotopes, a high enough concentration of
radioactivity may be built up in the
tumour tissues to obtain a local thera-
peutic effect.
In the present study we have expanded
the results from a previous investigation
(Denckeretat., 1979). Thefollowingexperi-
ments have been performed:
(1) Distribution studies of 14C-labelled
thiouracil in mice transplanted with
melanomas to estimate the total uptake
in thetumours according to the dose given
and compared to different organs in the
body.
We have also used animals from a pilot
investigation (to be published in another
context) on the therapeutic effect ofL. DENCKER, B. LARSSON, K. OLANDER AND S. ULLBERG
35S-thiouracil on melanoma tumour
growth in a few mice, for histological and
detailed distribution studies.
(2) We have further investigated the
dose-uptake relation in vivo in the tu-
mours of melanoma-bearing mice and in
vitro in cultured melanoma cells. The
question was whether the thiouracil in-
corporation into the melanin would reach
a saturation level at any dose between
tracer doses and toxic levels.
MATERIALS AND METHODS
Animals.-Melanotic Harding-Passey tu-
mours (obtained from AB Leo, Helsingborg,
Sweden) were transplanted s.c. in DBA, C3H
or in DBA x C3H F1 mice. Amelanotic S-91
tumours (obtained from the Department of
Tumour Biology, Karolinska Institutet,
Stockholm) were transplanted in DBA mice.
For continuous tumour supply, both tumours
were maintained in DBA mice. For trans-
plantation, small pieces of tumour were
passed through a mesh into a BSS-solution
(based salt solution). The cell suspension thus
obtained was then injected s.c. into the back
of the mice.
Labelled substances.-2-thio-(2-14C)uracil
(sp. act. 27 or 60 mCi/mmol) was obtained
from the Radiochemical Centre, Amersham,
England. 35S-thiouracil (sp. act. 50-8 mCi/
mmol) was purchased from New England
Nuclear (NEN), Boston, Mass. The substances
were dissolved in saline before injection.
Whole-body autoradiography (ARG).-
Isotope-injected animals intended for ARG
were killed at predetermined intervals after
injection of the labelled drugs by inhalation
of CO2. They were then mounted in a gel of
carboxymethyl cellulose and frozen in hexane
cooled with dry ice. Sections attached to tape
(No. 810, Minnesota Mining and Manufac-
turing Co.) were taken at different levels of
the body (Ullberg, 1954; 1977). Twenty- and
60-,um sections were collected for ARG and
100 ltm sections for cutting out pieces for
quantitative measurements. The sections
were freeze-dried and those intended for
ARG were apposed against X-ray film. After
exposure, 3-8 weeks for the 14C-thiouracil,
and 6 h to 7 days for the 35S-thiouracil (note
the high doses of 35S), the films were deve-
loped. Selected sections were stained with
hematoxylin-eosin and mounted in Euparal.
Scintillation counting.-Quantitative meas-
urements were made with tissues obtained
in different ways. Pieces were cut out
either from thick tape-fastened sections, or
from organs of the remaining parts of the
frozen mice after they had been sectioned for
ARG. Alternatively, they were dissected out
directly after the mice had been killed.
Melanin-containing tissues were dissolved in
1 ml Soluene 100i (Packard) and then
bleached by adding 0-2 ml H202 (35%) and
0-2 ml isopropanol. After incubation for
30 min at 40°C, 15 ml Instagel 0 (Packard)
was added. From the serum specimens 100 ,ul
was taken, to which 1 ml water and 10 ml
Instagel were added. Other tissues were
dissolved in 1 ml Soluene 350® (Packard).
The radioactivity was determined in a
Packard Tri-Carb Model 2405 liquid-scintilla-
tion spectrometer and quenching was cor-
rected for by the use ofan external standard.
All subsequent calculations were made on a
dry-weight basis.
The following experiments were per-
formed:
(a) Distribution of 14C-thiouracil in mice
with melanotic and amelanotic tumours.-Four
DBA x C3H F1 mice with melanotic mela-
nomas received one single i.v. dose of 10 jtCi
14C-thiouracil and were killed 1, 4 and 24 h
and 4 days later. These animals were used for
ARG and scintillation counting.
To complement this study, 18 DBA mice
with melanotic melanomas were divided into
6 groups of 3. Each animal received a single
i.v. dose of 10 ,uCi 14C-thiouracil. The
animals in each group were killed 2, 4, 24 and
48 h and 7 and 14 dayslater, respectively, for
scintillation counting. The results from these
two series are combined in Table I.
Three DBA mice with amelanotic mela-
nomas received a single i.v. dose of 5 uCi
14C-thiouracil and were killed 4 and 24 h and
4 days later for ARG and scintillation
counting; (Table I).
Five DBA x C3H F1 mice with melanotic
melanomas were injected i.p. with repeated
doses of 14C-thiouracil (ARG and scintillation
counting; details of dosages and survival
times in Table II).
(b) Distribution of 35S-thiouracil at high
doses in mice with melanotic melanomas.-Four
animals from a pilot study (in order to find a
proper dose of 35S-thiouracil for radiotherapy
in melanoma-bearing mice) were used here to
study the detailed distribution ofthe 35S. The
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doses and the time of treatment are given in
Table III. All animals received daily i.p.
injections of triiodothyronine (041 ,ug Lio-
thyronin-Na, Nyegaard & Co., A/S, Oslo)
during the first week, then one dose every
2 days to substitute for a possible discon-
tinuance of thyroid hormone production.
Nineteen days after initiation of the 35S-
thiouracil treatment, all the animals were
killed. The tumours were dissected and
weighed. The tumours of the 35S-thiouracil
treated animals were then cut in two sym-
metrical halves. One of them was put back
in situ and the animals were used for whole-
body ARG and scintillation counting as
described earlier. The other halves were fixed
in 3.5% buffered formalin and 5 pm sections
were cut for histological examination and for
stripping-film (Kodak AR 10) ARG according
to Doniach & Pele (1950).
(c) Distribution of 14C-thiouracil at different
dose levels in mice with melanotic melanomas.-
Twenty mice received 5 x 104 ct/min/g body
weightof14C-thiouraciltogetherwith different
doses ofunlabelled thiouracil. Thus 4 mice in
each 5 groups received i.p. doses of 25, 50,
100, 150 and 200 Hg/g respectively. The
animals were killed 48 h later and tumours,
tissues and serum were collected for scintil-
lation counting.
(d) In vitro uptake of 14C-thiouracil at
different concentrations in cultured melanoma
* vl q.) .
cells.-Harding-Passey melanotic melanoma
cells and S-91 amelanotic melanoma cells were
grown in a medium containing 50 ml foetal
calf serum, 450 ml RPMI 1640 (Flow Labor-
atories), 5 ml glutamine (4 M) with strepto-
mycin and penicillin added. The medium was
exchanged every 2 days. After the cells had
grown in vitro for 4-6 days, 5 x 103 ct/min/ml
of 14C-thiouracil and different amounts of
unlabelled thiouracil were added to the
medium. The final concentration ofthiouracil
in the medium was 0 3 (or 0.75), 2-5, 25, 250,
2500,M respectively. The cultures were dis-
continued 24 h later. The cells were washed
4 x in fresh culture medium and then incu-
bated with 0.25% trypsin and 0.02% Na-
EDTA in PBS for 20 min to loosen the cells.
The cells were counted in a Burker chamber,
and the radioactivity in the cells and super-
natant was measured separately.
RESULTS
Distribution
A4C-thiouracil.-After injection of 4C-
thiouracil into the mice, the radioactivity
disappeared rapidly from the body by
urinary and faecal excretion, and was not
retained in any normal organ with the
exception of the thyroid. As can be seen
in Table I and II and in Fig. 1, the
r\r/F I~~~~~VER
FIG. 1.-Whole-body autoradiogram of a mouse 24 h after i.v. injection of 14C-thiouracil. There is
high accumulation (white areas) in the melanotic tumour. The concentration within the tumour
varies greatly, apparently reflecting differences in the rate of melanin synthesis at the time of
injection. The concentration in the eye is low due to its low rate of melanin synthesis.
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FIG. 2.-Whole-body autoradiogram of a melanoma-bearing mouse 16 days after the last of 4 daily
i.p. injections of 35S-thiouracil. Note the selective accumulation in melanotic tumour, particularly
where there is presumed to have been a high rate of melanin synthesis at the time of injection.
There is also an uptake in the skin and cartilage, most probably due to free 35S, and in the thyroid
(thiouracil is a thyrostatic drug).
melanotic melanomas andthethyroidwere
the only tissues showing considerably
higher concentration ofradioactivity than
the body average. After a single injection,
a marked accumulation in the melanotic
tumours could be registered at 4 h. The
highest relative tumour concentration
compared to the other organs was
reached first at 24-48 h (Fig. 1; Table I).
At 4 days and later, the concentration in
the tumours was decreasing, most prob-
ably due to dilution by tumour growth.
Certain areas of the tissues reached a
tumour/muscle concentration ratio as high
as 1097. In the tumour areas with the
highest concentrations, 217% g dose/g
tissue was measured. This represents the
mean of a rather large volume of tissue,
and even higher concentrations certainly
existed in restricted areas (see Figs 1 and
3). The eyes had a low activity.
Table III shows the relative concentra-
tion of35S in different tissues and tumours.
Again, only tumour tissues had a con-
centration much greater than muscle. It is
notable that the thyroids had a compara-
tively low concentration, which may be
an effect of the triiodothyronine treat-
ment. It should also be noted that testis
and kidney have higher relative uptake
than was seen for 14C-labelled thiouracil.
This was true also for cartilage and con-
nective tissues (ARG), which showed high
concentrations (Fig. 2). These deviations
from the 14C-thiouracil distribution pat-
tern was most probably a result of incor-
poration of 35S-sulphate after 35S had
been lost from the uracil moiety.
Fig. 3 is a photomicrograph of an
autoradiogram after 35S-thiouracil injec-
tion, showing the irregular distribution of
radioactivity. In zones of heavily labelled
cells, necrotic areas can be seen. The cells
with specially high activity have probably
been formed while high amounts of 35S-
thiouracil were accessible to them from the
blood.
Dose-uptake in vivo and in vitro
Fig. 4 shows the in vivo dose-uptake
relation of 14C-thiouracil in the tumours
and some other organs 48 h after adminis-
tration. For all organs studied, a rela-
tively linear increase in uptake with the
dose is seen. This indicates that the
capacity of the melanocytes in the mela-
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FIG. 3.-Photomicrograph showing an autoradiogram of the tumour of a melanoma-bearing mouse
16 days after the last of 4 daily i.p. injections of 35S-thiouracil. The lower part of the figure shows
heavily labelled cells (black spots) while the upper part, which probably represents younger
areas of the melanoma, lacks radioactivity.
nomas to incorporate thiouracil is not
saturated at doses which are near-toxic for
the animals. It also indicates that the
pharmacokinetics of thiouracil is not dose
dependent, at least not noticeably 48 h
after administration.
The in vitro dose-uptake relation of 140._
thiouracil (Table IV) confirms the in vivo
results. There is a linear uptake in both
melanotic and amelanotic cells, showing
that the thiouracil has free passage into
the cells. The approximately 10-fold
higher concentration ofradioactivityinthe
melanotic than in the amelanotic cells can
be explained mainly by incorporation of
label into melanin. The number of cells
was somewhat lower at the highest dose
level, indicating slight toxicity.
DISCUSSION
The idea of using drugs with selective
affinity for cellular receptors or other
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FIG. 4.-Thiouracil concentration in tumour
tissues and some other organs as a function
of dose; 48 h after a single i.p. dose of 14C-
thiouracil (tracer dose) plus different doses
of unlabelled thiouracil. For all organs
there is arelatively linear increase in uptake
with the dose given. The irregularities ofthe
curve for the tumour is most probably a
result of differences within each tumour
(see Fig. 1).
structures to draw cytotoxic moieties or
radioisotopes to tumour tissues is not new.
In the case of melanomas, radio-iodine-
labelled chloroquine analogues have been
tried (Beierwaltes et al., 1968) for the
detection of metastases or ocular melan-
omas, but have never been routinely used
clinically.
Thiouracil is more rapidly and com-
pletely cleared from normal tissues than
iodoquine. Another advantage with thio-
uracil is the low uptake in the normal
melanin of the adult, as it does not bind
to the preformed pigment.
This means that the melanin of the eye,
inner ear, substantia nigra of the brain
stem, and the skin will take up thiouracil
TABLE IV.-The in vitro uptake ofthioura-
cil in melanoma cells culturedfor 24 h in
different concentrations of unlabelled
thiouracil plus 140-thiouracil. Values are
means of 3-5 cultures with s.d. in
brackets.
Concentration Uptake x 10-4
Type of cell un medium (pum) (pmol/cell)
Melanotic 0*3 0*2 (0*02)
(Harding-Passey) 2-5 2-3 (0 5)
25 19 (3*1)
250 209 (56)
2500 2188 (1000)
Amelanotic 0 75 0.1 (0-01)
(S-91) 2-5 0 2 (0 03)
25 2-0 (0*3)
250 20 (2*3)
2500 98 (23)
only when there is growth in these tissues.
In the pre-adult mouse which was used
in our experiments, a slight, apparently
growth-related, ocular uptake was found.
This uptake decreases with age and is very
low in an old mouse (Dencker et al., 1981).
In the skin of a monkey, there was only a
minor uptake, mainly in hair follicles.
Therefore, the radiation dose to the
various tissues (because oftheir amount of
normal melanin) will be low in middle
aged and old individuals.
Thiouracil is steadily incorporared into
melanin during its synthesis. In this way a
very high concentration of thiouracil will
be reached in young tumour areas, in or
very close to melanocytes which are just
being formed, and therefore most sensitive
to radiation. There will not be a heavy
load of radioactivity in "resting" tumour
areas. Thus, except for its accumulation
in the thyroid, the thiouracil is about as
close one may come to the ideal drug for
specificity.
It is not clear from our experiments
whether fractionated dosing will increase
the relative uptake in melanomas, but
during therapy continuous administration
will probably be preferred, as it will
maintain a continuous high concentration
of radioactive drug in the proliferative
zones of the tumour.
Our dose-uptake studies give informa-
tion important to the possible clinical use =-----.E,a~~~~~ose
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of thiouracil. As the uptake in melanin is
not saturable at a wide range of doses, a
low specific activity of labelled thiouracil
may be acceptable.
The 35S incorporated into cartilage (for
example) probably results from metabolic
breakdown of thiouracil. If 1251 would be
used to label thiouracil, free 1251 would
appear in the body. Iodine is, however,
rapidly excreted, except for what is
accumulated in the thyroid. The thyroid
problem, however, has to be dealt with
in any case, as thiouracil itselfis a thyroid
seeker. The uptake of radio-iodine in the
thyroid may be drastically reduced by a
simultaneous administration of thyroid
hormones, antithyroid drugs or non-
radioactive iodide. In addition we have
found that the accumulation of thiouracil
in the thyroid gland is substantially
decreased by pretreatment with thyroid
hormones (Olander et al., to be published).
It is possible that other more or less
related drugs may be as selectively
incorporated into melanin as thiouracil.
We have shown earlier (Dencker et al.,
1981) that the sulphur is essential for the
incorporation into melanin, as uracil and
fluorouracil are not incorporated specifi-
ally. The cyclic structure ofthiouracil may
be important, since thiourea is incorpor-
ated less selectively than thiouracil. We
have proposed that the firm binding
between the thiouracil molecule and
melanin consists of a condensation of the
sulphydryl group of thiouracil with quin-
ones produced in the melanin synthesis.
This mechanism would thus resemble the
binding between melanin and the protein
matrix of melanosomes (Nicolaus, 1968).
Similar binding has been proposed by
Whittaker (1971) for the thiouracil accu-
mulation in melanin in vitro.
We have preliminary results showing
that 5-iodo-2-thiouracil (labelled with
1251) accumulates in melanotic melanomas
in a similar manner to thiouracil. Such
preparations, labelled with a suitable
radioiodine isotope (e.g. 1311) may be the
drugs of choice for clinical use, both for
diagnosis and therapy.
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